High-sensitivity C-reactive protein, low-density lipoprotein cholesterol, and cardiovascular outcomes in patients with type 2 diabetes in the EXAMINE (Examination of Cardiovascular Outcomes With Alogliptin Versus Standard of Care) trial
Diabetes, Obesity and Metabolism Nov 04, 2017
Hwang YC, et al. - This research was designed to evaluate the risk of major adverse cardiovascular events (MACE) by utilizing high-sensitivity C-reactive protein (hsCRP) level and low-density lipoprotein cholesterol (LDL-C) in patients with type 2 diabetes and recent acute coronary syndrome. Among patients with type 2 diabetes and recent acute coronary syndrome, levels of hsCRP were correlated with recurrent cardiovascular events. This association was also appeared to be independent of and additive to the achieved LDL-C level.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
